KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) FCF Margin: 2018-2025

Historic FCF Margin for Adaptive Biotechnologies (ADPT) over the last 7 years, with Sep 2025 value amounting to -8.02%.

  • Adaptive Biotechnologies' FCF Margin rose 5101.00% to -8.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -24.90%, marking a year-over-year increase of 3971.00%. This contributed to the annual value of -55.25% for FY2024, which is 4284.00% up from last year.
  • Per Adaptive Biotechnologies' latest filing, its FCF Margin stood at -8.02% for Q3 2025, which was up 63.92% from -22.22% recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year FCF Margin high stood at -8.02% for Q3 2025, and its period low was -353.94% during Q2 2023.
  • In the last 3 years, Adaptive Biotechnologies' FCF Margin had a median value of -59.03% in 2024 and averaged -92.97%.
  • Its FCF Margin has fluctuated over the past 5 years, first slumped by 23,400bps in 2023, then spiked by 30,987bps in 2024.
  • Adaptive Biotechnologies' FCF Margin (Quarterly) stood at -166.28% in 2021, then spiked by 10,729bps to -58.99% in 2022, then plummeted by 267bps to -61.66% in 2023, then spiked by 3,517bps to -26.49% in 2024, then soared by 5,101bps to -8.02% in 2025.
  • Its last three reported values are -8.02% in Q3 2025, -22.22% for Q2 2025, and -56.71% during Q1 2025.